...
【24h】

On-line blood viscosity monitoring in vivo with a central venous catheter, using electrical impedance technique

机译:使用电阻抗技术通过中央静脉导管在线监测体内血液粘度

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Blood viscosity is an important determinant of microvascular hemodynamics and also reflects systemic inflammation. Viscosity of blood strongly depends on the shear rate and can be characterized by a two parameter power-law model. Other major determinants of blood viscosity are hematocrit, level of inflammatory proteins and temperature. In-vitro studies have shown that these major parameters are related to the electrical impedance of blood. A special central venous catheter was developed to measure electrical impedance of blood in-vivo in the right atrium. Considering that blood viscosity plays an important role in cerebral blood flow, we investigated the feasibility to monitor blood viscosity by electrical bioimpedance in 10 patients during the first 3 days after successful resuscitation from a cardiac arrest. The blood viscosity-shear rate relationship was obtained from arterial blood samples analyzed using a standard viscosity meter. Non-linear regression analysis resulted in the following equation to estimate in-vivo blood viscosity (Viscosity_(imp)) from plasma resistance (R_p), intracellular resistance (R_i) and blood temperature (T) as obtained from right atrium impedance measurements:Viscosity_(imp)=(-15.574+15.576R_pT)SR ~((-.138RpT-.290Ri)). This model explains 89.2% (R~2=.892) of the blood viscosity-shear rate relationship. The explained variance was similar for the non-linear regression model estimating blood viscosity from its major determinants hematocrit and the level of fibrinogen and C-reactive protein (R~2=.884). Bland-Altman analysis showed a bias between the in-vitro viscosity measurement and the in-vivo impedance model of .04mPas at a shear rate of 5.5s~(-1) with limits of agreement between -1.69mPas and 1.78mPas. In conclusion, this study demonstrates the proof of principle to monitor blood viscosity continuously in the human right atrium by a dedicated central venous catheter equipped with an impedance measuring device. No safety problems occurred and there was good agreement with in-vitro measurements of blood viscosity.
机译:血液粘度是微血管血流动力学的重要决定因素,也反映了全身性炎症。血液的粘度在很大程度上取决于剪切速率,并且可以通过两个参数的幂律模型来表征。血液粘度的其他主要决定因素是血细胞比容,炎性蛋白水平和温度。体外研究表明,这些主要参数与血液的电阻抗有关。开发了一种特殊的中心静脉导管以测量右心房中体内血液的电阻抗。考虑到血液粘度在脑血流中起重要作用,我们调查了在成功进行心脏骤停复苏后的前3天中,通过电生物阻抗监测10位患者血液粘度的可行性。从使用标准粘度计分析的动脉血样品获得血液粘度-剪切速率关系。非线性回归分析得出以下方程式,可根据从右心房阻抗测量获得的血浆电阻(R_p),细胞内电阻(R_i)和血液温度(T)估算体内血液粘度(Viscosity_(imp)): (imp)=(-15.574 + 15.576R_pT)SR〜((-。138RpT-.290Ri))。该模型解释了89.2%(R〜2 = .892)的血液粘度-剪切率关系。对于从其主要决定因素血细胞比容和纤维蛋白原和C反应蛋白水平估算血液粘度的非线性回归模型中,所解释的方差相似(R〜2 = .884)。 Bland-Altman分析表明,在5.5s〜(-1)的剪切速率下,体外粘度测量与0.04mPas的体内阻抗模型之间存在偏差,其极限在-1.69mPas和1.78mPas之间。总之,这项研究证明了通过配备有阻抗测量装置的专用中央静脉导管连续监测人体右心房中血液粘度的原理证明。没有发生安全问题,并且与体外测量血液粘度有很好的一致性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号